TGM2 inhibits the proliferation, migration and tumorigenesis of MDCK cells
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0285136 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Zhenyu Qiu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Northwest Minzu University, Biomedical Research Center, Gansu Tech Innovation Center of Animal Cell, Lanzhou, China. Hauptthemen laut MEDLINE: Influenza A virus, Influenza A Virus, H1N1 Subtype. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Scientific research innovation project of Northwest Minzu University, Graduate Research and Innovation Projects of Jiangsu Province.
Abstract (Originalsprache)
Madin-Darby canine kidney (MDCK) cells are one of the main cell lines used for influenza vaccine production due to their high virus yield and low mutation resistance. Due to their high tumorigenicity, the safety of vaccines produced from these cells is controversial. TGM2 is a multifunctional protein that plays an important role in the adhesion and migration of cells and is associated with tumor formation. We found that the expression level of TGM2 was significantly up-regulated in low tumorigenic MDCK cells. We first analyzed TGM2-overexpressed and knockout MDCK cells in vitro. Scratch-wound assay and Transwell chamber experiments showed that TGM2 overexpression significantly inhibited the migration and invasion of MDCK cells and significantly reduced their proliferation. TGM2 knockout significantly enhanced cell migration, invasion, and proliferation. The tumorigenesis results in nude mice were consistent with those in vitro. TGM2 knockout significantly enhanced the tumorigenesis rate of MDCK cells in nude mice. We also investigated the effects of TGM2 gene expression on the replication of the H1N1 influenza A virus in MDCK cells. The results showed that TGM2 induced the negative regulation of H1N1 replication. These findings contribute to a comprehensive understanding of the tumor regulation mechanism and biological functions of TGM2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Northwest Minzu University, Biomedical Research Center, Gansu Tech Innovation Center of Animal Cell, Lanzhou, China.
- Life Science and Engineering College of Northwest Minzu University, Lanzhou, China.
- Northwest Minzu University, Biomedical Research Center, Key Laboratory of Biotechnology & Bioengineering of State Ethnic Affairs Commission, Lanzhou, China.
- National Engineering Technology Research Center of Combined Vaccines, Wuhan, China.
- China National Biotec Group Company Limited, Beijing, China.
Förderung
- the National Natural Science Foundation of China
- the Scientific research innovation project of Northwest Minzu University
- Graduate Research and Innovation Projects of Jiangsu Province
Zitieren
APA
Qiu, Z., Guo, S., Liu, G., Pei, M., Liao, Y., Wang, J., Zhang, J., Yang, D., Qiao, Z., Li, Z., Ma, Z., Liu, Z., & Yang, X. (2023). TGM2 inhibits the proliferation, migration and tumorigenesis of MDCK cells. PLOS ONE. https://doi.org/10.1371/journal.pone.0285136
Vancouver
Qiu Z, Guo S, Liu G, Pei M, Liao Y, Wang J, et al. TGM2 inhibits the proliferation, migration and tumorigenesis of MDCK cells. PLOS ONE. 2023. doi:10.1371/journal.pone.0285136
BibTeX
@article{Qiu2023,
author = {Qiu, Zhenyu and Guo, Shouqing and Liu, Geng and Pei, Mengyuan and Liao, Yuejiao and Wang, Jiamin and Zhang, Jiayou and Yang, Di and Qiao, Zilin and Li, Zhuo and Ma, Zhongren and Liu, Zhenbin and Yang, Xiaoming},
title = {TGM2 inhibits the proliferation, migration and tumorigenesis of MDCK cells},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0285136}
}
EUVIMED